Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-21-038823

Options or other derivatives

  • Chief Medical Officer acquired 275,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Humphrey Jeffrey Chief Medical Officer 2021-10-01 Grant or award · Stock Option (Right to Buy) +275,000 275,000 D
Loading xslF345X03/doc4.xml…